bpc-157 subcutaneous or intramuscular Peptide Subcutaneous Peptide Injection

Safety evaluation: The safety of the cream is assessed through acute toxicity tests, long-term toxicity tests, etc., to ensure that it has no toxic or side effects

We are very happy to answer any questions you might have before signing up

Contraindications BPC-157 peptide therapy is not recommended for individuals who: Have active or recent cancer Are pregnant or breastfeeding Are under the age of 18 A full medical consultation is required before starting any peptide protocol

Response: Based on the comment received, we find that this medical device is used to deliver a therapy to reduce postoperative pain or produce post-surgical or regional analgesia